-
Women who switch to the NuvaRing contraceptive vaginal ring (Organon, Roseland, NJ) from other forms of hormonal contraception experience reduced hormone-related adverse events, according to results from a study presented at the recent European Society of Contraception in Istanbul, Turkey.1
-
Your next patient is a 35-year-old mother of two who is experiencing ongoing heavy menstrual bleeding (menorrhagia). Recently remarried, she says she may want to have a child in the future with her new partner. What are your treatment options?
-
For years, the much talked-about male contraceptive pill has remained tantalizingly out of reach. What if the first contraceptive method to reach the commercial market relied on a nonhormonal approach instead?
-
When discussing spermicides with prospective users, family planning providers in the United States have only nonoxynol-9 (N-9) formulations in the contraception arsenal. What if there were other formulations added to the mix?
-
Research findings have suggested higher failure rates in oral contraceptive (OC) users who are heavy; however, new results from a retrospective analysis of Phase III efficacy data of a popular ethinyl estradiol/norgestimate formulation (Ortho Tri-Cyclen Lo, Ortho McNeil Pharmaceutical; Raritan, NJ) indicate that it is not associated with an increased risk of pregnancy in such women.
-
Unplanned pregnancies carry extra health risks for obese women. In a 2005 study, researchers found that overweight women (BMI 25-29.9) had increased risks of diabetes, hypertension, pre-eclampsia, and cesarean delivery, with even higher risks for obese women (BMI 30 and above).
-
-
"As many as 98,000 deaths per year are due to errors in hospital care.1" ... "A RAND Health study found that only 54.9% of patients received recommended care.2"
-
Do long-acting beta agonist inhalers increase the severity of asthma? Yes, according to the results from a large meta-analysis recently published in the Annals of Internal Medicine.
-
